MEDICAL DICTIONARY
MEF2A: A transcription factor that participates in vascular development. MEF2A is a member of the myocyte enhancer factor-2 (MEF2) family of transcription factors. Messenger RNA ( mRNA ) from MEF2A has been detected in blood vessels during early embryogenesis. The gene for MEF2A is located on chromosome 15q26.
A heritable deletion within the MEF2A gene that results in the loss of 7 amino acids appears responsible for an autosomal dominant form of coronary artery disease. The deletion alters the cellular distribution of the MEF2A protein and may prevent its function as a vascular transcription factor. It remains to be seen if the MEF2A pathway plays a role in the common form of coronary artery disease resulting from atherosclerosis .
MEF2A is also known as MADS box transcription enhancer factor 2, polypeptide A.
|
DISCLAIMER:
Information on this site is provided for informational
purposes and is not meant to substitute for the advice
provided by your own physician or other medical professional.
You should not use the information contained herein
for diagnosing or treating a health problem or disease,
or prescribing any medication. You should read carefully
all product packaging. Not all Canadian drugs, Canada
prescription and Canadian prescription medicine is available
at discount Canadian on line pharmacies. If you have
or suspect that you have a medical problem, promptly
contact your health care provider. Information and statements
regarding diet supplements have not been evaluated by
Health Canada and are not intended to diagnose, treat,
cure, or prevent any disease. All trade and service
marks mentioned on this site are recognized as belonging
to their respective owners.
|
|
|
|
